CRSP โ€“ 30-Min Short Trade Setup !

53
๐Ÿ“‰ ๐Ÿ”ป
๐Ÿ”น Asset: CRISPR Therapeutics AG (CRSP โ€“ NASDAQ)
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Bearish Pennant Breakdown + Retest Rejection

๐Ÿ“Š Trade Plan (Short Position)
โœ… Entry Zone: Below $31.30 (Confirmed Breakdown)
โœ… Stop-Loss (SL): Above $33.58 (White Resistance Level)

๐ŸŽฏ Take Profit Targets:
๐Ÿ“Œ TP1: $28.56 (Mid-support zone)
๐Ÿ“Œ TP2: $25.61 (Key demand area)

๐Ÿ“ Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk (SL Distance):
$33.58 - $31.30 = $2.28 risk per share
๐Ÿ“ˆ Reward to TP1:
$31.30 - $28.56 = $2.74 โ†’ R/R = 1:1.20
๐Ÿ“ˆ Reward to TP2:
$31.30 - $25.61 = $5.69 โ†’ R/R = 1:2.49

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Bearish Pennant Breakdown: Price broke the pattern and is now rejecting the yellow zone on a retest.
๐Ÿ“Œ Lower Highs + Breakdown Structure: Indicates weakness, confirming bearish bias.
๐Ÿ“Œ Support Levels Below: Room to fall towards multiple levels of structure.
๐Ÿ“Œ Volume Check: Look for continued weak volume on bounce to confirm lack of demand.

๐Ÿ“‰ Trade Execution & Risk Management
๐Ÿ“Š Entry Trigger: Break and hold below $31.30 with weak bullish reaction.
๐Ÿ“‰ Trailing Stop Strategy: Move SL to breakeven once TP1 is hit.
๐Ÿ’ฐ Partial Profit Booking:
โœ” Close 50% position at $28.56
โœ” Let remaining ride toward $25.61
โœ” Adjust SL to breakeven after TP1

โš ๏ธ Setup Invalidation
โŒ Strong bullish reversal candle with volume above $33.58
โŒ Consolidation above yellow zone after false breakdown
โŒ Positive news or catalyst reversing trend

๐Ÿšจ Final Thoughts
โœ” Clean breakdown pattern with confluence resistance at $33.58
โœ” Bearish trend intact with lower highs and breakdowns
โœ” High probability setup with strong R/R potential
๐Ÿ’ก Stick to the plan, manage risk, and let the chart do the talking.

๐Ÿ”— #CRSP #OptionsTrading #NASDAQStocks #TradingSetup #BearishTrade #ProfittoPath #SwingTradeSetup #RiskReward #ChartAnalysis #TradingView

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.